Fennec Pharmaceuticals (FENC) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Fennec Pharmaceuticals (FENC) over the last 15 years, with Q3 2025 value amounting to -$224.6 million.
- Fennec Pharmaceuticals' Retained Earnings fell 318.79% to -$224.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$224.6 million, marking a year-over-year decrease of 318.79%. This contributed to the annual value of -$219.7 million for FY2024, which is 19.89% down from last year.
- As of Q3 2025, Fennec Pharmaceuticals' Retained Earnings stood at -$224.6 million, which was down 318.79% from -$224.0 million recorded in Q2 2025.
- Over the past 5 years, Fennec Pharmaceuticals' Retained Earnings peaked at $215.6 million during Q3 2023, and registered a low of -$224.6 million during Q3 2025.
- In the last 5 years, Fennec Pharmaceuticals' Retained Earnings had a median value of -$207.8 million in 2023 and averaged -$179.8 million.
- Its Retained Earnings has fluctuated over the past 5 years, first soared by 20981.45% in 2023, then tumbled by 20096.61% in 2024.
- Over the past 5 years, Fennec Pharmaceuticals' Retained Earnings (Quarter) stood at -$175.1 million in 2021, then fell by 16.08% to -$203.2 million in 2022, then decreased by 7.9% to -$219.2 million in 2023, then decreased by 0.2% to -$219.7 million in 2024, then dropped by 2.26% to -$224.6 million in 2025.
- Its last three reported values are -$224.6 million in Q3 2025, -$224.0 million for Q2 2025, and -$220.8 million during Q1 2025.